A detailed history of Mangrove Partners transactions in Bausch & Lomb Corp stock. As of the latest transaction made, Mangrove Partners holds 1,151,292 shares of BLCO stock, worth $20.7 Million. This represents 2.89% of its overall portfolio holdings.

Number of Shares
1,151,292
Previous 1,151,292 -0.0%
Holding current value
$20.7 Million
Previous $16.7 Million 32.85%
% of portfolio
2.89%
Previous 1.88%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$13.6 - $17.06 $15.7 Million - $19.6 Million
1,151,292 New
1,151,292 $16.7 Million
Q1 2023

May 15, 2023

BUY
$15.67 - $18.91 $2.89 Million - $3.49 Million
184,623 Added 23.59%
967,397 $16.8 Million
Q3 2022

Nov 14, 2022

BUY
$14.23 - $17.76 $11.1 Million - $13.9 Million
782,774 New
782,774 $12 Million

Others Institutions Holding BLCO

About Bausch & Lomb Corp


  • Ticker BLCO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 350,000,000
  • Market Cap $6.3B
  • Description
  • Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replace...
More about BLCO
Track This Portfolio

Track Mangrove Partners Portfolio

Follow Mangrove Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mangrove Partners, based on Form 13F filings with the SEC.

News

Stay updated on Mangrove Partners with notifications on news.